GL1X · GenesisL1 explorer

Research workbench

Crystal structure of multidrug resistant HIV-1 protease clinical isolate PR20 with the potent antiviral inhibitor grl-02031

Analyse Crystal structure of multidrug resistant HIV-1 protease clinical isolate PR20… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4J55
Type
protein
Length
198 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Protease
EC
3.4.23.16
UniProt
P03367
Ligands
031
Pockets
1 · best druggability 0.69

Structure

x-ray diffraction · 1 distinct chain · 7% helix, 53% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BProtease (EC 3.4.23.16)protein997% helix, 53% strandP03367

Ligands and binding sites

  • 031 · (3aS,5R,6aR)-hexahydro-2H-cyclopenta[b]furan-5-yl [(1S,2R)-1-benzyl-2-hydroxy-3-([(4-methoxyphenyl)sulfonyl]{[(2R)-5-oxopyrrolidin-2-yl]methyl}amino)propyl]carbamate · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13930.690.8135031

Interfaces

1 interface between chains.

  • A–B · 1829 Ų buried · 34 hydrogen bonds · protein-protein

Compared structures

  • 4J55 · Crystal Structure of Multidrug Resistant HIV-1 Protease Clinical isolate PR20 with the… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.